Advertisement · 728 × 90

Posts by Joe Maakaron

The #EBMT26 coverage seems spotty. Can #leusm and #bmtsm communities make sure @hemedoc.bsky.social attends all conferences please? Do I need to cover his clinic or what?

@hemedoc.bsky.social, your Impact Factor is >9000 at this point

4 weeks ago 0 0 1 0

I read this as CART is feasible in r/r BL and could serve as a bridge to allogeneic transplant given encouraging CR rates but short duration of response.

8 months ago 1 0 0 0

I said: Revumenib in AML and Dara in SMM. I got an email that I need to expand on these. I said that they weren't there and now they are so I can use them. I get the above email that "ASH Reviewers" denied my CME.

Absolutely bonkers!

1 year ago 0 0 0 0
Post image

#ASH24 #nonsense

@ash-hematology.bsky.social

Thank you #ASH24 for a fun meeting and all the education. Also, thank you for easy CME process:

Step ONE: Pay $30 before anything else. OK
Step TWO: Pick and EVALUATE EACH session you attended. Fine makes sense.
Step THREE: Write a statement

1 year ago 0 0 1 0

Also, HTN as the reason for being anthracycline ineligible in 80% is fairly arguable.

1 year ago 1 0 1 0
Post image Post image

#ASH24
#BMTsm
Pierini -
1. Novel conditioning regimens: TMLI
2. Graft manipulation Treg/Tcon or a/b(-)
3. Donor selection: NK cell reactivity and others

1 year ago 2 0 0 0
Post image Post image

#ASH24
Reducing post allo relapse - Vago
Knowledge of mechanism of relapse post allo is important to direct therapeutics

Generic HLA loss
Epigenetic loss of HLA II
Offending drugs and genotoxic/microbiotic

#BMTsm

1 year ago 2 0 0 0
Post image

#ASH24
#CeleBMTies

Dr. Steve Devine needs no introduction. One of the greatest BMT investigators of my time. Now starting and running transformative trials through the @nmdp-org.bsky.social

1 year ago 0 1 0 0
Advertisement

Dr. Logan's presence on #Bluesky should immediately attract whoever is still on the other platform.

#ASH24
#BestSlideSummaries
#WhatAreWeCallingThese skies? Posts? Blues?

1 year ago 3 0 0 0
Post image

#ASH24
#BMTsm
#CeleBMTies
#BMTmemories

Dr. Mukta Arora spotted at ASH. Seminal contributions to the field of GVHD.

1 year ago 4 0 0 0
Post image

#ASH24

Is it a bird? Is it a new CAR-T? Nope. Just good tacos.
Wish you all lines this long for your presentations!

1 year ago 4 0 0 0

Is Amer Zidan here?

1 year ago 0 0 0 0
Post image Post image

#ASH24

Airport registration is a nice touch. No line.

Taxi.. different story. #carpool

1 year ago 5 0 1 0

Really enjoying Bluesky #bsky as I get ready to go to #ASH24
Feels like the old days with good science and nice people. Looking forward to seeing everyone there!

#BMTsm

1 year ago 3 0 0 0
Paper: What Is the Optimal Dose of MMF in Single Cord Blood Transplantation?: A Single-Center Analysis of MMF Dosage for GVHD Prophylaxis and Its Impact on Outcomes

MMF is not all good. In fact, might be pretty detrimental for engraftment in high doses (and RFS in some papers).

#ASH24
#BMTsm

ash.confex.com/ash/2024/web...

1 year ago 1 0 0 0
Paper: Safety and Efficacy of the Glucagon-like Peptide 2 (GLP-2) Analog Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease (aGvHD) in Combination with Be...

ash.confex.com/ash/2024/web...

GLP-2 agonist for treatment of aGVHD. 31 patients, mostly with G 3/4 GVHD. ORR ~50% with durable CRs of ~30%. 11 patients with G5 events - unrelated to study drug. Unmet need for non-immunosuppressive therapies
#ASH24
#BMTsm

1 year ago 7 1 0 0